Literature DB >> 27495174

Non-invasive ventilation for sleep-disordered breathing in Smith-Magenis syndrome.

Victoria Connor1, Sizheng Zhao2, Robert Angus1.   

Abstract

Smith-Magenis syndrome (SMS) is a rare genetic neurodevelopmental disorder characterised by behavioural disturbances, intellectual disability and early onset obesity. The physical features of this syndrome are well characterised; however, behavioural features, such as sleep disturbance, are less well understood and difficult to manage. Sleep issues in SMS are likely due to a combination of disturbed melatonin cycle, facial anatomy and obesity-related ventilatory problems. Sleep disorders can be very distressing to patients and their families, as exemplified by our patient's experience, and can worsen behavioural issues as well as general health. This case demonstrates the successful use of non-invasive ventilation in treating underlying obesity hypoventilation syndrome and obstructive sleep apnoea. As a consequence of addressing abnormalities in sleep patterns, some behavioural problems improved. 2016 BMJ Publishing Group Ltd.

Entities:  

Mesh:

Year:  2016        PMID: 27495174      PMCID: PMC4986049          DOI: 10.1136/bcr-2016-215621

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  7 in total

1.  Daytime somnolence in an adult with Smith-Magenis syndrome.

Authors:  Toshiki Takenouchi; Hideyuki Saito; Naoki Oishi; Hiroyuki Fukushima; Rika Kosaki; Chiharu Torii; Takao Takahashi; Kosaki Kenjiro
Journal:  Am J Med Genet A       Date:  2013-05-17       Impact factor: 2.802

2.  Circadian rhythm abnormalities of melatonin in Smith-Magenis syndrome.

Authors:  L Potocki; D Glaze; D X Tan; S S Park; C D Kashork; L G Shaffer; R J Reiter; J R Lupski
Journal:  J Med Genet       Date:  2000-06       Impact factor: 6.318

3.  Multi-disciplinary clinical study of Smith-Magenis syndrome (deletion 17p11.2)

Authors:  F Greenberg; R A Lewis; L Potocki; D Glaze; J Parke; J Killian; M A Murphy; D Williamson; F Brown; R Dutton; C McCluggage; E Friedman; M Sulek; J R Lupski
Journal:  Am J Med Genet       Date:  1996-03-29

4.  Hypoventilation in REM sleep in a case of 17p11.2 deletion (Smith-Magenis syndrome).

Authors:  Chiara Leoni; Laura Cesarini; Serena Dittoni; Domenica Battaglia; Antonio Novelli; Laura Bernardini; Anna Losurdo; Catello Vollono; Elisa Testani; Giacomo Della Marca; Giuseppe Zampino
Journal:  Am J Med Genet A       Date:  2010-03       Impact factor: 2.802

Review 5.  Smith-Magenis syndrome.

Authors:  Sarah H Elsea; Santhosh Girirajan
Journal:  Eur J Hum Genet       Date:  2008-01-30       Impact factor: 4.246

6.  Efficacy of risperidone treatment in Smith-Magenis syndrome (del 17 pll. 2).

Authors:  Helmut Niederhofer
Journal:  Psychiatr Danub       Date:  2007-09       Impact factor: 1.063

7.  Molecular analysis of the Smith-Magenis syndrome: a possible contiguous-gene syndrome associated with del(17)(p11.2).

Authors:  F Greenberg; V Guzzetta; R Montes de Oca-Luna; R E Magenis; A C Smith; S F Richter; I Kondo; W B Dobyns; P I Patel; J R Lupski
Journal:  Am J Hum Genet       Date:  1991-12       Impact factor: 11.025

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.